Literature DB >> 10688721

Newer strategies for effective evaluation of primary melanoma and treatment of stage III and IV disease.

P Walsh1, P Gibbs, R Gonzalez.   

Abstract

Our objective in this article is to update dermatologists on the clinical management of malignant melanoma, including the role of sentinel node biopsy and options for the treatment of stage III and stage IV disease. The role of the dermatologist throughout the continuum of care is emphasized, and the essential partnership with medical oncology in recognizing promising new options for patients with advanced disease is examined.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10688721     DOI: 10.1016/s0190-9622(00)90223-8

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  3 in total

1.  From melanocyte to metastatic malignant melanoma.

Authors:  Bizhan Bandarchi; Linglei Ma; Roya Navab; Arun Seth; Golnar Rasty
Journal:  Dermatol Res Pract       Date:  2010-08-11

2.  Surgery and adjuvant therapies in the treatment of stage IV melanoma: our experience in 84 patients.

Authors:  Francesca Tauceri; Gianni Mura; Mauro Roseano; Massimo Framarini; Laura Ridolfi; Giorgio M Verdecchia
Journal:  Langenbecks Arch Surg       Date:  2008-03-04       Impact factor: 3.445

3.  Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases.

Authors:  P Radny; U M Caroli; J Bauer; T Paul; C Schlegel; T K Eigentler; B Weide; M Schwarz; C Garbe
Journal:  Br J Cancer       Date:  2003-11-03       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.